We are joined by Jason Shuris, Chief Business Officer at Innovaderm. With 25 years of experience in healthcare and life sciences, Jason shares his insights on the advantages of niche CROs. The episode covers his deep scientific knowledge, strategic trial expertise, and understanding of disease-related endpoints. Tune in for this enlightening conversation!